Arvinas, Inc. announced it raised $32.5 Million in an initial filing from an offering of $32.5 Million

Jul 21, 2019•over 6 years ago

Amount Raised

$32.5 Million

New HavenBiotechnology

Company Information

Company

ARVINAS, INC.

Location

395 WINCHESTER AVE

New Haven, Kentucky, United States

About

Arvinas is a pharmaceutical company focused on protein degradation approaches to develop novel drugs to treat cancer and other diseases.

0 contacts

No contacts found in Executives department

Try selecting a different department above

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech